OpenVSafe by OpenVAERS
Search V-safe

DFD-16897-59182

2 vaccinations 11 coded responses 25 check-ins 11 free-text entries 0 call cases
Sex
Male
Age at first dose
56-60
ZIP prefix
917 / CA
Registered
2021-03-30
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-30
    Registered in v-safe
  2. 2021-03-30
    Dose 1 — Moderna
  3. 2021-03-30
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Abdominal pain
    Adult check-in
  5. 2021-04-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Nausea, Abdominal pain
    Adult check-in
  6. 2021-04-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Nausea, Abdominal pain
    Adult check-in
  7. 2021-04-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea, Abdominal pain
    Adult check-in
  8. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Nausea, Abdominal pain
    Adult check-in
  9. 2021-04-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Nausea
    Adult check-in
  10. 2021-04-06
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain · Nausea
    Adult check-in
  11. 2021-04-13
    Survey response — day 14, dose 1
    MedDRA: Dyspepsia, Erythema, Nausea — Feeling: Good
    Free text: Nausea, dyspepsia.Redness at deltoid site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-20
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-04-27
    Dose 2 — Moderna
  14. 2021-04-27
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  15. 2021-04-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood glucose increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Increased Blood Glucose Level
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood glucose increased — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Further increase in Blood Glucose level
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood glucose increased, Night sweats — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Continue elevated glucose level. Night sweating.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-05-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood glucose increased — Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches, Nausea, Abdominal pain
    Free text: Glucose level lower, still elevated
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Blood glucose abnormal — Feeling: Good · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain
    Free text: Glucose returning to normal range
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-05-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Unevaluable event — Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Abdominal pain
    Free text: Glucose level improvement
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-05-04
    Survey response — day 7, dose 2
    MedDRA: Blood glucose increased — Feeling: Good · Site: Pain · Muscle or body aches, Nausea, Abdominal pain
    Free text: Glucose level elevated
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-05-11
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-05-18
    Survey response — day 21, dose 2
    MedDRA: Dizziness — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Light headed
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-05-25
    Survey response — day 28, dose 2
    MedDRA: Asthenia, Headache, Injection site discomfort, Nausea, Syncope — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Syncope, discomfort at injection site, increased nausea and weakness headache in early hours upon waking
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-06-01
    Survey response — day 35, dose 2
    MedDRA: Abdominal discomfort, Disorientation, Hyperglycaemia, Syncope — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Strange abdomen discomfort, rates 2, periods hyperglycemia, mild syncope, and mild disorientation.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-06-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-27
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-26
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-30Moderna
22021-04-27Moderna

Free text

Release 7 — day 14, dose 1

2021-04-13

Symptoms: Nausea, dyspepsia.Redness at deltoid site.

Release 8 — days 1–6 daily, dose 2

2021-04-28

Systemic reaction (other): Increased Blood Glucose Level

2021-04-29

Systemic reaction (other): Further increase in Blood Glucose level

2021-04-30

Systemic reaction (other): Continue elevated glucose level. Night sweating.

2021-05-01

Systemic reaction (other): Glucose level lower, still elevated

2021-05-02

Systemic reaction (other): Glucose returning to normal range

2021-05-03

Systemic reaction (other): Glucose level improvement

Release 8 — day 7, dose 2

2021-05-04

Systemic reaction (other): Glucose level elevated

Release 8 — day 21, dose 2

2021-05-18

Symptoms: Light headed

Release 8 — day 28, dose 2

2021-05-25

Symptoms: Syncope, discomfort at injection site, increased nausea and weakness headache in early hours upon waking

Release 8 — day 35, dose 2

2021-06-01

Symptoms: Strange abdomen discomfort, rates 2, periods hyperglycemia, mild syncope, and mild disorientation.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal discomfort ✓ ✓ ✓
SDAsthenia ✓ ✓ ✓
SDDisorientation ✓ ✓ ✓
SDDizziness ✓ ✓ ✓
SDDyspepsia ✓ ✓ ✓
SDErythema ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHyperglycaemia ✓ ✓ ✓
SDInjection site discomfort ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDSyncope ✓ ✓ ✓
SROBlood glucose abnormal ✓ ✓ ✓
SROBlood glucose increased ✓ ✓ ✓
SRONight sweats ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release